George Donohue in New York, New York

Home New York New York

George Donohue has Physician Assistant as his primary medical specialty. Their primary office is: 1275 York Ave in New York, New York. There is an additional office location, for a total of two, for George Donohue that can be viewed further down.

They're a part of the: Mskcc Surgery Group medical group which has around 271 members. You can call their office at 212-639-2000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Philadelphia College Of Osteopathic Medicine and graduated in 2015 (around 10 years of experience). They are listed as doing telehealth appointments.

George F Donohue Office Phone and Directions

George Donohue
Mskcc Surgery Group
1275 York Ave
New York, New York 10065
212-639-2000

Patient Ratings
Please rate your experience with George Donohue below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-639-2000

Enter a starting address:

Healthcare Info for George Donohue

Medical School: Philadelphia College Of Osteopathic Medicine
Graduation Year: 2015
The Primary Medical Specialty for George Donohue is listed as: Physician Assistant
Approximate Years of Experience: 10
PAC (PECOS ID)#: 4688904865
NPI #: 1669983136
NPI Created On: 10/23/2017
NPI Last Updated Listed as: 10/23/2017
Primary Taxonomy Code: 363AS0400X
License Number:
021536
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Subsequent hospital inpatient care, typically 35 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 836031195

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: POLIVY

Open Associated Drug #1: 50242-105-01